AlAbdi L, Maddirevula S, Shamseldin HE, Khouj E, Helaby R, Hamid H, Almulhim A, Hashem MO, Abdulwahab F, Abouyousef O (2023) Diagnostic implications of pitfalls in causal variant identification based on 4577 molecularly characterized families. Nat Commun 14:5269
Article CAS PubMed PubMed Central Google Scholar
Apperley J (2009) Issues of imatinib and pregnancy outcome. J Natl Compr Canc Netw 7:1050–1058
Article CAS PubMed Google Scholar
Brasher BB, Van Etten RA (2000) c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J Biol Chem 275:35631–35637
Article CAS PubMed Google Scholar
Chen CA, Crutcher E, Gill H, Nelson TN, Robak LA, Jongmans MC, Pfundt R, Prasad C, Berard RA, Fannemel M (2020) The expanding clinical phenotype of germline ABL1-associated congenital heart defects and skeletal malformations syndrome. Hum Mutat 41:1738–1744
Article CAS PubMed Google Scholar
Dingemans AJM, Hinne M, Truijen KMG, Goltstein L, van Reeuwijk J, de Leeuw N, Schuurs-Hoeijmakers J, Pfundt R, Diets IJ, den Hoed J, de Boer E, Coenen-van der Spek J, Jansen S, van Bon BW, Jonis N, Ockeloen CW, Vulto-van Silfhout AT, Kleefstra T, Koolen DA, Campeau PM, Palmer EE, Van Esch H, Lyon GJ, Alkuraya FS, Rauch A, Marom R, Baralle D, van der Sluijs PJ, Santen GWE, Kooy RF, van Gerven MAJ, Vissers L, de Vries BBA (2023) PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework. Nat Genet 55:1598–1607. https://doi.org/10.1038/s41588-023-01469-w
Article CAS PubMed Google Scholar
El Gendy M, Kandil A, Helal M, Zahou F (2015) The teratogenic effects of imatinib mesylate on rat fetuses. Toxicol Rep 2:654–663
Article PubMed PubMed Central Google Scholar
Greuber EK, Smith-Pearson P, Wang J, Pendergast AM (2013) Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer 13:559–571
Article CAS PubMed PubMed Central Google Scholar
Hildebrandt CC, Patel N, Graham JM Jr, Bamshad M, Nickerson DA, White JJ, Marvin CT, Miller DE, UoWCfM G, Grand KL (2021) Further delineation of van den Ende-Gupta syndrome: Genetic heterogeneity and overlap with congenital heart defects and skeletal malformations syndrome. Am J Med Genet A 185:2136–2149
Article CAS PubMed Google Scholar
Klein AD, Kessel AGV, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765–767
Li B, Boast S, De LosSantos K, Schieren I, Quiroz M, Teitelbaum SL, Tondravi MM, Goff SP (2000) Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Gene 24:304–308
Melo Rito MT, Freitas I, Pinto-Basto J, Kay T, Antunes D (2019) Germline ABL1variant identified in a Nepalese girl with congenital heart defects and skeletal malformations syndrome: a case report 23rd Annual Meeting of the Portuguese Society of Human Genetics, Coimbra, Portugal. Wolters Kluwer Health, Inc., pp p e19291
Nussinov R, Tsai C-J, Jang H (2022) How can same-gene mutations promote both cancer and developmental disorders? Sci Adv. https://doi.org/10.1126/sciadv.abm2059
Article PubMed PubMed Central Google Scholar
Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF (2008) The effects of imatinib on pregnancy outcome. Blood J Am Soc Hematol 111:5505–5508
Qi H, Dong C, Chung WK, Wang K, Shen Y (2016) Deep genetic connection between cancer and developmental disorders. Hum Mutat 37:1042–1050
Article PubMed PubMed Central Google Scholar
Qiu Z, Cang Y, Goff SP (2010) c-Abl tyrosine kinase regulates cardiac growth and development. Proc Natl Acad Sci 107:1136–1141
Article CAS PubMed Google Scholar
Schwartzberg PL, Goff SP, Robertson EJ (1989) Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246:799–803
Article CAS PubMed Google Scholar
Schwartzberg PL, Stall AM, Hardin JD, Bowdish KS, Humaran T, Boast S, Harbison ML, Robertson EJ, Goff SP (1991) Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165–1175
Article CAS PubMed Google Scholar
Spencer C, Comitis G, Lawrenson J, Fieggen K (2023) ABL1-related congenital heart defects and skeletal malformations syndrome in a patient from Sub-Saharan Africa: a case report highlighting novel cardiac features. Am J Med Genet A 191:1652–1655
Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, Goldstein J, Ghosh R, Seifert BA, Sneddon TP (2017) Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am J Hum Genet 100:895–906
Article CAS PubMed PubMed Central Google Scholar
Testoni E, Stephenson NL, Torres-Ayuso P, Marusiak AA, Trotter EW, Hudson A, Hodgkinson CL, Morrow CJ, Dive C, Brognard J (2016) Somatically mutated ABL 1 is an actionable and essential NSCLC survival gene. EMBO Mol Med 8:105–116
Article CAS PubMed PubMed Central Google Scholar
Thaxton C, Goldstein J, DiStefano M, Wallace K, Witmer PD, Haendel MA, Hamosh A, Rehm HL, Berg JS (2022) Lumping versus splitting: how to approach defining a disease to enable accurate genomic curation. Cell Genomics 2:100131
Article CAS PubMed PubMed Central Google Scholar
Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153–1163
Article CAS PubMed Google Scholar
Wang X, Charng W-L, Chen C-A, Rosenfeld JA, Al Shamsi A, Al-Gazali L, McGuire M, Mew NA, Arnold GL, Qu C (2017) Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations. Nat Genet 49:613–617
Article CAS PubMed PubMed Central Google Scholar
Webb MJ, Jafta D (2012) Imatinib use in pregnancy. Turk J Haematol 29:405
留言 (0)